Your browser doesn't support javascript.
loading
Long non-coding RNA UCA1 desensitizes breast cancer cells to trastuzumab by impeding miR-18a repression of Yes-associated protein 1.
Zhu, Hua-Yu; Bai, Wen-Dong; Ye, Xing-Ming; Yang, An-Gang; Jia, Lin-Tao.
Afiliação
  • Zhu HY; Department of Immunology, Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Bai WD; Department of Immunology, Fourth Military Medical University, Xi'an, Shaanxi, China; Department of Clinical Laboratory Center, Xinjiang Command General Hospital of Chinese People's Liberation Army, Urumqi, Xinjiang, China.
  • Ye XM; Fujian Cancer Hospital & Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular, Biology, Fourth Military Medical University, Xi'an, Shaanxi, China.
  • Yang AG; Department of Immunology, Fourth Military Medical University, Xi'an, Shaanxi, China. Electronic address: agyang@fmmu.edu.cn.
  • Jia LT; State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular, Biology, Fourth Military Medical University, Xi'an, Shaanxi, China. Electronic address: lintaojia73@163.com.
Biochem Biophys Res Commun ; 496(4): 1308-1313, 2018 02 19.
Article em En | MEDLINE | ID: mdl-29408336

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / RNA Longo não Codificante / Trastuzumab Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / MicroRNAs / RNA Longo não Codificante / Trastuzumab Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article